An LMU research team led by Professor Olivia M. Merkel, Chair of Drug Delivery at LMU, has developed a new delivery system ...

NIAID is conducting early phase clinical trials on select next generation vaccine candidates with the intent to identify the most effective platforms and delivery routes OCU500 will be tested as both ...

Novel hybrid polymer nanocarriers enable effective vaccine delivery in the lungs and the targeted activation of immune cells. An LMU research team led by Professor Olivia M. Merkel, Chair of Drug ...

It’s hard to think of vaccination without associating it with a sharp jab in the arm. But there are other, more gentle ways of activating the immune system, such as administering vaccines via the nose ...

Nasal vaccines offer convenience and another option for those wary of needles, but traditional vaccines are best for young ...

A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated ...

In a phase I trial, an intranasal adjuvanted recombinant influenza vaccine appeared to result in response to a range of H5N1 clades. The adjuvanted vaccine elicited seroconversion against clade 2 ...

Newborns of mothers vaccinated against pertussis (whooping cough) during pregnancy have antibodies not only in their blood ...